NEO-SYNALAR Drug Patent Profile
✉ Email this page to a colleague
When do Neo-synalar patents expire, and when can generic versions of Neo-synalar launch?
Neo-synalar is a drug marketed by Medimetriks Pharms and is included in one NDA.
The generic ingredient in NEO-SYNALAR is fluocinolone acetonide; neomycin sulfate. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluocinolone acetonide; neomycin sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEO-SYNALAR?
- What are the global sales for NEO-SYNALAR?
- What is Average Wholesale Price for NEO-SYNALAR?
Summary for NEO-SYNALAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Clinical Trials: | 2 |
| Drug Prices: | Drug price information for NEO-SYNALAR |
| DailyMed Link: | NEO-SYNALAR at DailyMed |
Recent Clinical Trials for NEO-SYNALAR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Noah Rosenberg, MD | Phase 4 |
| LEO Pharma | Phase 1 |
Pharmacology for NEO-SYNALAR
| Drug Class | Aminoglycoside Antibacterial Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for NEO-SYNALAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medimetriks Pharms | NEO-SYNALAR | fluocinolone acetonide; neomycin sulfate | CREAM;TOPICAL | 060700-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
